Nishan - Stem Cell Therapy in Duchenne Muscular Dystrophy (DMD) - 23-04-2014
stem cell india, stem cell therapy india, stem cell in india, stem cell therapy in india, india stem cell, india stem cell therapy.
By: Stem Cell India
Go here to see the original:
Nishan - Stem Cell Therapy in Duchenne Muscular Dystrophy (DMD) - 23-04-2014 - Video
Scientists to clone Michael Jackson using stem cells
Scientists to clone Michael Jackson using stem cells.
By: jfjfjfhdhd
View post:
Scientists to clone Michael Jackson using stem cells - Video
01 Cells and cell division 09 Embryonic stem cells
By: Free Education
Read the original:
01 Cells and cell division 09 Embryonic stem cells - Video
SAT SiriusXM Interview
Howard Greenman, CEO of Provia laboratories and Store-A-Tooth, talks about stem cells and regenerative medicine on Wharton Business Radio.
By: storeatooth
See the original post here:
SAT SiriusXM Interview - Video
Autism complex treatment with stem cell therapy
Get free medical consultation http://www.rivertender.com rivertenderkiev@gmail.com +380636800002.
By:
Read more here:
Autism complex treatment with stem cell therapy - Video
Swastik - Stem Cell Therapy in Duchenne Muscular Dystrophy (DMD) - 23-06-2014
stem cell india, stem cell therapy india, stem cell in india, stem cell therapy in india, india stem cell, india stem cell therapy.
By: Stem Cell India
The rest is here:
Swastik - Stem Cell Therapy in Duchenne Muscular Dystrophy (DMD) - 23-06-2014 - Video
Xia Jie.
Medical entrepreneur Xia Jie, whose company Health 100 owns the largest chain of health clinics in China, plans to open overseas facilities to cater for wealthy clients.
That could result in an investment of about $20 million in a regenerative treatment centre in the resort, making it a Mecca for health tourism and athlete injury rehabilitation.
''We're now negotiating with the local medical teams,'' Mr Xia said yesterday through an interpreter while on a four-day fact-finding mission to Queenstown.
''Health 100 really wants to find beautiful cities around the world to take Chinese patients to and Queenstown is one of them.
''The vision is to bring the very high-end customers to have special treatment which is not carried out elsewhere in the world,'' he said.
Health 100 would invest with existing firms Queenstown Regenerative Medicine (QRM), run by Marcelle Noble, and the Queenstown Skin Institute.
Both have small premises at Remarkables Park in Frankton.
Queenstown Skin Institute director Dr Hans Raetz said Mr Xia had indicated plans for a much larger centre, with sites in Remarkables Park, Jacks Point or the Five Mile development off Frankton Ladies Mile already earmarked.
''The size depends on Mr Xia, but we've been talking between $10 million and $20 million.
Read the original post:
Stem cell centre proposed for resort
Stemedix Stem Cell Therapy for ALS - Patient Experience: Dr. Robert K., MD
Stemeidx treats Dr. Robert K., MD. for ALS (Amyotrophic Lateral Sclerosis). Dr. Robert speaks about his patient experience with Stemedix after receiving Stemedix adipose stem cell treatment....
By: Stemedix
See the rest here:
Stemedix Stem Cell Therapy for ALS - Patient Experience: Dr. Robert K., MD - Video
New undergraduate course about science fiction and stem cells
Visit USC on YouTube: http://www.youtube.com/usc Learn more about the University of Southern California: http://www.usc.edu USC is pleased to introduce a new undergraduate course starting...
By: USC
See the original post:
New undergraduate course about science fiction and stem cells - Video
(PRWEB UK) 22 September 2014
BioKidz is a simple concept which aims to engage children in the importance of stem cell medicine. Aimed at an audience of 4-9 year olds, the company now aims to use it in the 21 countries in which it operates.
BioEden has been invited to speak with parents and teachers later this month, as the BioKidz site aims to be a good source of scientific information for primary school teachers.
The BioEden proposition is very simple one: harvest the stem cells from a naturally shed baby tooth, store the viable cells for future therapeutic use, and guarantee that the cells will be available when needed.
As stem cell medicine is now becoming commonplace, it is important that there is a stem cell match when needed. The easiest way to do this is by harvesting and storing one's own cells, and there is no easier way than from naturally shed teeth.
The company admits that they could be putting the ordinary tooth fairy out of business, but they hasten to add that BioKidz have their own hero in the form of a Super Tooth Fairy who works within their own stem cell laboratories.
Children can meet BioEden the Super Tooth Fairy by visiting http://www.bioeden.com.
Read this article:
BioKidz: the Children of the Stem Cell Revolution to go Global
Daniel Kraft Interview - Singularity University - C100 CEO Summit
Daniel Kraft shows off his mini-me and talks about 3d printing organs and other body parts using stem cells with Daniel Kraft at Rosewood Sand Hill.
By: kris krg
Continued here:
Daniel Kraft Interview - Singularity University - C100 CEO Summit - Video
Will This New Stem Cell Treatment End The Controversy?
Embryonic stem cells are pluripotent, meaning they can become almost any type of cell. Since stem cell research is so controversial, researchers might have found a more ethical way to use stem...
By: DNews
Read more from the original source:
Will This New Stem Cell Treatment End The Controversy? - Video
Inflammatory Bowel Disease (IBD) Stem Cell Research: Ophir Klein, UCSF
By: California Institute for Regenerative Medicine
See the original post here:
Inflammatory Bowel Disease (IBD) & Stem Cell Research: Ophir Klein, UCSF - Video
Pevonia Stem Cells Phyto-Elite Line Review + Giveaway
Head over to BeingZhenya.com to enter for a chance to win one of 5 sample kits. #PevoniaLife Disclosure: This video was created in partnership with Pevonia. ...
By: BeingZhenya
Read more here:
Pevonia Stem Cells Phyto-Elite Line Review + Giveaway - Video
A Trojan horse in the fight against cancer | Marina Cihova | TEDxBratislava
This talk was given at a local TEDx event, produced independently of the TED Conferences. Marna Cihov presents her fascinating research of the therapeutic potential of stem cells in cancer...
By: TEDx Talks
Read the original here:
A Trojan horse in the fight against cancer | Marina Cihova | TEDxBratislava - Video
Fibroblast Growth Factor FGF Stem Cells 360p
to order your Laminine Pls txt/call Ronald Torrefiel +63 932 919 3383 Phils.
By: Ronald Torrefiel
Read more:
Fibroblast Growth Factor FGF & Stem Cells 360p - Video
Stem Cell Therapy Professional Football Player
James Lee a Professional Football player is back in action thanks to stem cell therapy and Dr. Dennis M. Lox MD. Dr. Lox | http://www.drloxstemcells.com | (844) 440-8503.
By: Dr. Lox
Read more:
Stem Cell Therapy Professional Football Player - Video
9 Global Options Stem Cell Therapy for Parkinson #39;s Disease
Parkinson #39;s disease is a neuromuscular condition that affects millions of people around the world. Uncontrollable movement of the body muscles along with strong shaking and trembling of extremiti...
By: placidways
Read more here:
9 Global Options Stem Cell Therapy for Parkinson's Disease - Video
Cellular therapeutics -- using intact cells to treat and cure disease -- is a hugely promising new approach in medicine but it is hindered by the inability of doctors and scientists to effectively track the movements, destination and persistence of these cells in patients without resorting to invasive procedures, like tissue sampling.
In a paper published September 17 in the online journal Magnetic Resonance in Medicine, researchers at the University of California, San Diego School of Medicine, University of Pittsburgh and elsewhere describe the first human tests of using a perfluorocarbon (PFC) tracer in combination with non-invasive magnetic resonance imaging (MRI) to track therapeutic immune cells injected into patients with colorectal cancer.
"Initially, we see this technique used for clinical trials that involve tests of new cell therapies," said first author Eric T. Ahrens, PhD, professor in the Department of Radiology at UC San Diego. "Clinical development of cell therapies can be accelerated by providing feedback regarding cell motility, optimal delivery routes, individual therapeutic doses and engraftment success."
Currently, there is no accepted way to image cells in the human body that covers a broad range of cell types and diseases. Earlier techniques have used metal ion-based vascular MRI contrast agents and radioisotopes. The former have proven difficult to differentiate in vivo; the latter raise concerns about radiation toxicity and do not provide the anatomical detail available with MRIs.
"This is the first human PFC cell tracking agent, which is a new way to do MRI cell tracking," said Ahrens. "It's the first example of a clinical MRI agent designed specifically for cell tracking."
Researchers used a PFC tracer agent and an MRI technique that directly detects fluorine atoms in labeled cells. Fluorine atoms naturally occur in extremely low concentrations in the body, making it easier to observe cells labeled with fluorine using MRI. In this case, the modified and labeled dendritic cells -- potent stimulators of the immune system -- were first prepared from white blood cells extracted from the patient. The cells were then injected into patients with stage 4 metastatic colorectal cancer to stimulate an anti-cancer T-cell immune response.
The published study did not assess the efficacy of the cell therapy, but rather the ability of researchers to detect the labeled cells and monitor what happened to them. Ahrens said the technique worked as expected, with the surprising finding that only half of the delivered cell vaccine remained at the inoculation site after 24 hours.
"The imaging agent technology has been to shown to be able to tag any cell type that is of interest," Ahrens said. "It is a platform imaging technology for a wide range of diseases and applications," which might also speed development of relevant therapies.
"Non-invasive cell tracking may help lower regulatory barriers," Ahrens explained. "For example, new stem cell therapies can be slow to obtain regulatory approvals in part because it is difficult, if not impossible, with current approaches to verify survival and location of transplanted cells. And cell therapy trials generally have a high cost per patient. Tools that allow the investigator to gain a 'richer' data set from individual patients mean it may be possible to reduce patient numbers enrolled in a trial, thus reducing total trial cost."
Story Source:
Visit link:
Better way to track emerging cell therapies using MRIs
Edgar Irastorza was just 31 when his heart stopped beating in October 2008.
A Miami property manager, Irastorza had recently gained weight as his wife's third pregnancy progressed. "I kind of got pregnant, too," he said.
During a workout one day, he felt short of breath and insisted that friends rush him to the hospital. Minutes later, his pulse flatlined. He survived the heart attack, but the scar tissue that resulted cut his heart's pumping ability by a third. He couldn't pick up his children. He fell asleep every night wondering if he would wake up in the morning.
Desperation motivated Irastorza to volunteer for a highly unusual medical research trial: getting stem cells injected directly into his heart. "I just trusted my doctors and the science behind it, and said, 'This is my only chance,' " he said recently.
Over the last five years, by studying stem cells in lab dishes, test animals and intrepid patients like Irastorza, researchers have brought the vague, grandiose promises of stem cell therapies closer to reality.
Stem cells broke into the public consciousness in the early 1990s, alluring for their potential to help the body beat back diseases of degeneration like Alzheimer's, and to grow new parts to treat conditions like spinal cord injuries.
Progress has been slow. But researchers are learning how to best use stem cells, what types to use and how to deliver them to the body findings that are not singularly transformational, but progressive and pragmatic.
As many as 4,500 clinical trials involving stem cells are under way in the United States to treat patients with heart disease, blindness, Parkinson's, HIV, blood cancers and spinal cord injuries, among other conditions.
Initial studies suggest that stem cell therapy can be delivered safely, said Dr. Ellen Feigal, senior vice president of research and development at the California Institute of Regenerative Medicine, the state stem cell agency, which has awarded more than $2 billion toward stem cell research since 2006.
But enthusiasm for stem cells sometimes outstrips the science. When Gov. Rick Perry of Texas had adult stem cells injected into his spine in 2011 for a back injury, his surgeon had never tried the procedure and had no data to support the experiment. A June review in the New England Journal of Medicine found that "platelet-rich plasma" stem cell therapies praised by a number of athletes worked no better than placebos.
Read the original here:
Stem cell revolution gets closer